BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37803049)

  • 21. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.
    Abo Elwafa R; Abd Elrahman A; Ghallab O
    Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion.
    Yang L; Bai HS; Deng Y; Fan L
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3187-93. PubMed ID: 26400521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b.
    Sun Z; Zhang T; Chen B
    Med Sci Monit; 2019 Feb; 25():1410-1422. PubMed ID: 30793707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of
    Ahmadi A; Kaviani S; Yaghmaie M; Pashaiefar H; Ahmadvand M; Jalili M; Alimoghaddam K; Eslamijouybari M; Ghavamzadeh A
    Blood Res; 2018 Dec; 53(4):320-324. PubMed ID: 30588470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transformation in Low-grade B-cell Neoplasms.
    Montgomery ND; Mathews SP
    Surg Pathol Clin; 2016 Mar; 9(1):79-92. PubMed ID: 26940269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
    Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
    Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
    Mao TL; Fan MH; Dlamini N; Liu CL
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma are biclonal lymphomas: a report of two cases.
    Boiocchi L; Witter RE; He B; Subramaniyam S; Mathew S; Nie K; Cerutti A; Coleman M; Knowles DM; Orazi A; Tam W
    Am J Clin Pathol; 2012 Apr; 137(4):647-59. PubMed ID: 22431543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma.
    Kim SH; Kim SH; Yang WI; Kim SJ; Yoon SO
    Oncotarget; 2017 May; 8(19):31305-31317. PubMed ID: 28412742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
    Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
    Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
    Covach A; Patel S; Hardin H; Lloyd RV
    Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer.
    Ou X; Gao G; Bazhabayi M; Zhang K; Liu F; Xiao X
    J Cancer Res Ther; 2019; 15(7):1597-1602. PubMed ID: 31939443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway.
    Li Y; Liu YD; Chen SL; Chen X; Ye DS; Zhou XY; Zhe J; Zhang J
    Mol Hum Reprod; 2019 Jan; 25(1):17-29. PubMed ID: 30371869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy.
    Dahl M; Kristensen LS; Grønbæk K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MALAT1-breast cancer interplay: insights and implications.
    Tufail M
    Expert Rev Mol Diagn; 2023; 23(8):665-678. PubMed ID: 37405385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
    Herishanu Y; Pérez-Galán P; Liu D; Biancotto A; Pittaluga S; Vire B; Gibellini F; Njuguna N; Lee E; Stennett L; Raghavachari N; Liu P; McCoy JP; Raffeld M; Stetler-Stevenson M; Yuan C; Sherry R; Arthur DC; Maric I; White T; Marti GE; Munson P; Wilson WH; Wiestner A
    Blood; 2011 Jan; 117(2):563-74. PubMed ID: 20940416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Richter syndrome: molecular insights and clinical perspectives.
    Rossi D; Gaidano G
    Hematol Oncol; 2009 Mar; 27(1):1-10. PubMed ID: 19206112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome.
    Trimech M; Letourneau A; Missiaglia E; De Prijck B; Nagy-Hulliger M; Somja J; Vivario M; Gaulard P; Lambert F; Bisig B; de Leval L
    Am J Surg Pathol; 2021 Jun; 45(6):773-786. PubMed ID: 33739791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal B cell lymphocytosis and "in situ" lymphoma.
    Karube K; Scarfò L; Campo E; Ghia P
    Semin Cancer Biol; 2014 Feb; 24():3-14. PubMed ID: 23999128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profile of serial samples of transformed B-cell lymphomas.
    de Vos S; Hofmann WK; Grogan TM; Krug U; Schrage M; Miller TP; Braun JG; Wachsman W; Koeffler HP; Said JW
    Lab Invest; 2003 Feb; 83(2):271-85. PubMed ID: 12594241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.